Induction of MIF expression by oxidized LDL via activation of NF-κB in vascular smooth muscle cells

Atherosclerosis

Volumn 207, Issue 2, 2009, Pages 428-433

  Chen, Lihong ^a   Yang, Guangrui ^a   Zhang, Xiaoyan ^a   Wu, Jing ^a   Gu, Qing ^b   Wei, Mingfen ^a   Yang, Jichun ^a   Zhu, Yi ^a   NanpingWang, ^a   Guan, Youfei ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b FUWAI HOSPITAL   (China)

Author keywords

Atherosclerosis; MIF; NF B; oxLDL; VSMCs

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BINDING SITE; CONTROLLED STUDY; DNA LIBRARY; GENE DELETION; GENE MUTATION; GENETIC TRANSFECTION; MALE; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RABBIT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

AMINO ACID SEQUENCE; ANIMALS; ATHEROSCLEROSIS; BINDING SITES; CELLS, CULTURED; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; I-KAPPA B PROTEINS; INTRAMOLECULAR OXIDOREDUCTASES; LIPOPROTEINS, LDL; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RABBITS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; UP-REGULATION;

EID: 70450257720     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.05.021     Document Type: Article

References (34)

1. Hoi A.Y., Iskander M.N., and Morand E.F. Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases. Inflamm Allergy Drug Targets 6 (2007) 183-190
2. Burger-Kentischer A., Goebel H., Seiler R., et al. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 105 (2002) 1561-1566
3. Schmeisser A., Marquetant R., Illmer T., et al. The expression of macrophage migration inhibitory factor 1alpha (MIF 1alpha) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability. Atherosclerosis 178 (2005) 83-94
4. Lin S.G., Yu X.Y., Chen Y.X., et al. De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res 87 (2000) 1202-1208
5. Pan J.H., Sukhova G.K., Yang J.T., et al. Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 109 (2004) 3149-3153
6. Burger-Kentischer A., Gobel H., Kleemann R., et al. Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF). Atherosclerosis 184 (2006) 28-38
7. Kong Y.Z., Yu X., Tang J.J., et al. Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques. Atherosclerosis 178 (2005) 207-215
8. Kong Y.Z., Huang X.R., Ouyang X., et al. Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques. Cardiovasc Res 65 (2005) 272-282
9. Lue H., Kleemann R., Calandra T., Roger T., and Bernhagen J. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 4 (2002) 449-460
10. de Winther M.P., Kanters E., Kraal G., and Hofker M.H. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 25 (2005) 904-914
11. Wilson S.H., Caplice N.M., Simari R.D., et al. Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia. Atherosclerosis 148 (2000) 23-30
12. Brand K., Page S., Rogler G., et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 97 (1996) 1715-1722
13. Hajra L., Evans A.I., Chen M., et al. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci USA 97 (2000) 9052-9057
14. Verhoye E., and Langlois M.R. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?. Clin Chem Lab Med 47 (2009) 128-137
15. Maziere C., and Maziere J.C. Activation of transcription factors and gene expression by oxidized low-density lipoprotein. Free Radic Biol Med 46 (2009) 127-137
16. Steinbrecher U.P. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem 262 (1987) 3603-3608
17. Gu Q., Chen J., and Ruan Y. Inhibitory effects of aspirin, clopidogrel, and their combination on the progression of atherosclerosis in rabbits. Acta Acad Med Sin 27 (2005) 87-91
18. Yang G., Chen L., Zhang Y., et al. Expression of mouse membrane-associated prostaglandin E(2) synthase-2 (mPGES-2) along the urogenital tract. Biochim Biophys Acta 1761 (2006) 1459-1468
19. Ayoub S., Hickey M.J., and Morand E.F. Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis. Nat Clin Pract 4 (2008) 98-105
20. Ogawa H., Nishihira J., Sato Y., et al. An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine 12 (2000) 309-314
21. Atsumi T., Nishihira J., Makita Z., and Koike T. Enhancement of oxidised low-density lipoprotein uptake by macrophages in response to macrophage migration inhibitory factor. Cytokine 12 (2000) 1553-1556
22. Donnelly S.C., Haslett C., Reid P.T., et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3 (1997) 320-323
23. Chen Z., Sakuma M., Zago A.C., et al. Evidence for a role of macrophage migration inhibitory factor in vascular disease. Arterioscler Thromb Vasc Biol 24 (2004) 709-714
24. Schober A., Bernhagen J., Thiele M., et al. Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice. Circulation 109 (2004) 380-385
25. Bernhagen J., Krohn R., Lue H., et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13 (2007) 587-596
26. Okamoto T., Atsumi T., Shimizu C., Yoshioka N., and Koike T. The potential role of macrophage migration inhibitory factor on the migration of vascular smooth muscle cells. J Atherosc Thrombosis 15 (2008) 13-19
27. Andalibi A., Liao F., Imes S., Fogelman A.M., and Lusis A.J. Oxidized lipoproteins influence gene expression by causing oxidative stress and activating the transcription factor NF-kappa B. Biochem Soc Trans 21 Pt 3 (1993) 651-655
28. Ruef J., Moser M., Bode C., Kubler W., and Runge M.S. 4-Hydroxynonenal induces apoptosis, NF-kappaB-activation and formation of 8-isoprostane in vascular smooth muscle cells. Basic Res Cardiol 96 (2001) 143-150
29. Xanthoulea S., Curfs D.M., Hofker M.H., and de Winther M.P. Nuclear factor kappa B signaling in macrophage function and atherogenesis. Curr Opin Lipidol 16 (2005) 536-542
30. Cominacini L., Pasini A.F., Garbin U., et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 275 (2000) 12633-12638
31. Cominacini L., Garbin U., Fratta Pasini A., et al. Lacidipine inhibits the activation of the transcription factor NF-kappaB and the expression of adhesion molecules induced by pro-oxidant signals on endothelial cells. J Hypertension 15 (1997) 1633-1640
32. Robbesyn F., Salvayre R., and Negre-Salvayre A. Dual role of oxidized LDL on the NF-kappaB signaling pathway. Free Radic Res 38 (2004) 541-551
33. Amin M.A., Haas C.S., Zhu K., et al. Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood 107 (2006) 2252-2261
34. Daun J.M., and Cannon J.G. Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha. Am J Physiol 279 (2000) R1043-R1049